Sonnenblick A - Search Results

1

Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer.

Monteran L, Ershaid N, Doron H, Zait Y, Scharff Y, Ben-Yosef S, Avivi C, Barshack I, Sonnenblick A, Erez N. Monteran L, et al. Among authors: sonnenblick a. Nat Commun. 2022 Oct 2;13(1):5797. doi: 10.1038/s41467-022-33598-x. Nat Commun. 2022. PMID: 36184683 Free PMC article.

2

Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy.

Flashner-Abramson E, Vasudevan S, Adejumobi IA, Sonnenblick A, Kravchenko-Balasha N. Flashner-Abramson E, et al. Among authors: sonnenblick a. Theranostics. 2019 Jul 9;9(18):5149-5165. doi: 10.7150/thno.31657. eCollection 2019. Theranostics. 2019. PMID: 31410207 Free PMC article.

3

The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer.

Bar Y, Bar K, Itzhak I, Niselbaum CS, Dershowitz N, Shachar E, Weiss-Meilik A, Golan O, Wolf I, Menes T, Sonnenblick A. Bar Y, et al. Among authors: sonnenblick a. Breast. 2021 Dec;60:78-85. doi: 10.1016/j.breast.2021.09.002. Epub 2021 Sep 4. Breast. 2021. PMID: 34509707 Free PMC article.

4

[GENOMIC PROFILING IN LUMINAL BREAST CANCER].

Raphael A, Sonnenblick A. Raphael A, et al. Among authors: sonnenblick a. Harefuah. 2022 Feb;161(2):104-109. Harefuah. 2022. PMID: 35195972 Review. Hebrew.

5

The History of Early Breast Cancer Treatment.

Ben-Dror J, Shalamov M, Sonnenblick A. Ben-Dror J, et al. Among authors: sonnenblick a. Genes (Basel). 2022 May 27;13(6):960. doi: 10.3390/genes13060960. Genes (Basel). 2022. PMID: 35741721 Free PMC article. Review.

6

Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.

Alkhatib H, Conage-Pough J, Roy Chowdhury S, Shian D, Zaid D, Rubinstein AM, Sonnenblick A, Peretz-Yablonsky T, Granit A, Carmon E, Kohale IN, Boughey JC, Goetz MP, Wang L, White FM, Kravchenko-Balasha N. Alkhatib H, et al. Among authors: sonnenblick a. Mol Cancer. 2024 Jan 16;23(1):17. doi: 10.1186/s12943-023-01921-9. Mol Cancer. 2024. PMID: 38229082 Free PMC article.

7

Combining TIGIT blockage with MDSC inhibition hinders breast cancer bone metastasis by activating anti-tumor immunity.

Monteran L, Ershaid N, Scharff Y, Zoabi Y, Sanalla T, Ding Y, Pavlovsky A, Zait Y, Langer M, Caller T, Eldar-Boock A, Avivi C, Sonnenblick A, Satchi-Fainaro R, Barshack I, Shomron N, Zhang XH, Erez N. Monteran L, et al. Among authors: sonnenblick a. Cancer Discov. 2024 Mar 1. doi: 10.1158/2159-8290.CD-23-0762. Online ahead of print. Cancer Discov. 2024. PMID: 38427556

8

Update on current and new potential immunotherapies in breast cancer, from bench to bedside.

Alaluf E, Shalamov MM, Sonnenblick A. Alaluf E, et al. Among authors: sonnenblick a. Front Immunol. 2024 Feb 15;15:1287824. doi: 10.3389/fimmu.2024.1287824. eCollection 2024. Front Immunol. 2024. PMID: 38433837 Free PMC article. Review.

9

[Update: adjuvant trastuzumab in HER2 positive breast cancer].

Tahover E, Sonnenblick A, Peretz T, Katz D. Tahover E, et al. Among authors: sonnenblick a. Harefuah. 2012 Jan;151(1):37-42, 61. Harefuah. 2012. PMID: 22670500 Review. Hebrew.

10

Metastatic breast cancer: The Odyssey of personalization.

Sonnenblick A, Pondé N, Piccart M. Sonnenblick A, et al. Mol Oncol. 2016 Oct;10(8):1147-59. doi: 10.1016/j.molonc.2016.07.002. Epub 2016 Jul 11. Mol Oncol. 2016. PMID: 27430154 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page